{ "results": [ { "id": "d005a44c3b8ab85213b5e3db8e22185e", "title": "Director, Medical Information", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 201000, "salary_max": 251000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 201000, "base_salary_max": 251000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:36:39.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Information Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a motivated and experienced professional to join our team as a Director of Medical Information. This role focuses on ensuring the delivery of timely, accurate, and evidence-based responses to healthcare professionals (HCPs), patients, and caregivers. As a key member of the Medical Affairs team, you will oversee the creation and management of medical information content, support compendia submissions, and provide Medical Information support at congresses. The ideal candidate is a skilled communicator with a strong scientific background and can manage projects in a dynamic environment. Key Responsibilities: - Lead oversight and performance management of the global Medical Information call center, ensuring all customer inquiries are handled accurately, compliantly and within established timelines. - Maintains and monitors KPIs, and quality metrics, driving continuous improvement to ensure high-quality, consistent inquiry handling. - Prepares and presents regular reports on medical information performance metrics and outcomes to", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 7, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6124d6a4e262cae664", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d005a44c3b8ab85213b5e3db8e22185e", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e68e9da60b47a5f085", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d005a44c3b8ab85213b5e3db8e22185e", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.fdab74241a44f5da5e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "d005a44c3b8ab85213b5e3db8e22185e", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:d005a44c3b8ab85213b5e3db8e22185e:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "rule:remote_status" ], "checked_at": null }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695099003", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "c105e3535b716e6f76407b9a11159eb9", "title": "Associate Director, HEOR, Japan", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (Japan)", "country": "JP", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "UNSPECIFIED", "salary_type": "unknown", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-09T22:14:25.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, HEOR, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, HEOR Japan will provide execution, and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 48, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "growth-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 45, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0e45a1a6aae60e0f9d", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, HEOR, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, HEOR Japan will provide execution, and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c105e3535b716e6f76407b9a11159eb9:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.fdde5c8d8ba975d3e1", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, HEOR, Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, HEOR Japan will provide execution, and scientific leadership across health economics, outcomes research, and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across JPAC markets. They will work in concert with Global HEOR and other regional teams to deliver an Integrated Evidence Plan for each asset and disease area. The role will align HEOR evidence generation with market access, pricing & reimbursement, patient access strategies, and cross-functional planning. The Associate Director, HEOR Japan will report to the Executive Medical Director, Japan and a dotted line into the Global HEOR group. Key Responsibilities - Strategic Leadership: Define, drive and deliver upon a HEOR strategy within Japan in support of product lifecycle planning, value evidence generation, pricing/reimbursement, and access engagements. They will be accountable for delivering value demonstration - Integrated Evidence Planning: Participate within the Revolution Medicines IEP process and", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c105e3535b716e6f76407b9a11159eb9:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.09822d523b7559b1d4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c105e3535b716e6f76407b9a11159eb9:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.38c6c4ede4cdf0a0b7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:c105e3535b716e6f76407b9a11159eb9:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2699fed29bc77a6407", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6177ddcc8b382b38a4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "c105e3535b716e6f76407b9a11159eb9", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767687003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "93a9f546df4ddd1ef76b292d6ece1c4e", "title": "Director, Clinical Quality", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 201000, "salary_max": 251000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 201000, "base_salary_max": 251000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:29:26.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Clinical Quality Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director of Clinical Quality will play a key role in Quality Assurance and have direct responsibility for the clinical quality workstreams and study teams. This role is responsible for providing quality and compliance oversight for RevMed-sponsored clinical trials with respect to RevMed's Standard Operating Procedures, applicable regulatory requirements (FDA, EU, ICH & country-specific), and current industry standards and practices. This role will support daily compliance operational activities, evaluate risk, and resolve quality events for early phase through late-phase clinical programs. This role will also be responsible for managing multiple studies including GLP activities that impact clinical studies/data. This role will report to the Head of Clinical Quality. - Act as the study lead for Phase 3 program(s), provide support and guidance to the Clinical Development and Clinical Operations functions, including but not limited to the following functional areas: Global Patient Safety, Translational Medicine,", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.34adcd0f08e9f56a3c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "93a9f546df4ddd1ef76b292d6ece1c4e", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.fd55574b2e25f18330", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "93a9f546df4ddd1ef76b292d6ece1c4e", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.07475b84d92614c76e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "93a9f546df4ddd1ef76b292d6ece1c4e", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:93a9f546df4ddd1ef76b292d6ece1c4e:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7693917003", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "f106c4f2159a0f9119e40bd09b4eb568", "title": "Director, Medical Science Liaison (WA, OR, AK, MT, WY, ID, UT)", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 236000, "salary_max": 259000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 236000, "base_salary_max": 259000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-19T07:33:15.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Science Liaison (WA, OR, AK, MT, WY, ID, UT) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 60, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e632ef473fc91f678c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (WA, OR, AK, MT, WY, ID, UT) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f106c4f2159a0f9119e40bd09b4eb568:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.ef613fd2acecbe1bda", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (WA, OR, AK, MT, WY, ID, UT) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f106c4f2159a0f9119e40bd09b4eb568:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0e76154a60f4b302ff", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f106c4f2159a0f9119e40bd09b4eb568:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.655eea3a8fe3974142", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f106c4f2159a0f9119e40bd09b4eb568:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d0c5704e43e0f7ae5c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.db502c1a6c8988fbad", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f106c4f2159a0f9119e40bd09b4eb568", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739050003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "f0dc5f1a65b63a3dc99d009006b44864", "title": "Senior Director, Biostatistics, Europe", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (Switzerland)", "country": "CH", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "UNSPECIFIED", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:35:28.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Biostatistics, Europe Remote (Switzerland) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and the subject matter expert (SME) in Biostatistics within the Quantitative Sciences function, this position is to provide statistical leadership and support for EU access strategies, healthcare technology assessments and regulatory submissions. - Serve as the statistical lead for European access strategies, ensuring alignment between Global Clinical Development, European regulatory (EMA, MHRA, Swissmedic...) and regional/local Market Access needs to support successful European launches in collaboration with global and regional crossfunctional teams. - Partner with Regional and Local Market Access and HEOR functions to design and lead/oversee the execution of statistical analyses required for value dossiers, including PICO, indirect treatment comparisons, network meta-analyses, and RWE generation. - Partner closely with the development statistical lead, provide statistical support for EU regulatory interactions, including EMA Scientific Advice, MAA, Type II variations, and post-authorization commitments. - Ensure statistical methodologies", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 48, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": 12, "role_function": "data", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 45, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.cc7d63c044670c2db4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f0dc5f1a65b63a3dc99d009006b44864", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ec169d3185750aff75", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f0dc5f1a65b63a3dc99d009006b44864", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.6804da8b141bb86a71", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "f0dc5f1a65b63a3dc99d009006b44864", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "data", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:f0dc5f1a65b63a3dc99d009006b44864:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7694347003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "fe67fffa8f0de0487f438e51c90baa42", "title": "Director, Medical Science Liaison (MI, WI, MN)", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 236000, "salary_max": 259000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 236000, "base_salary_max": 259000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-14T22:14:28.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Medical Science Liaison (MI, WI, MN) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 60, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.1ef360498b66dfe2e7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (MI, WI, MN) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fe67fffa8f0de0487f438e51c90baa42:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.9a02a229efd3d6b0ae", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Medical Science Liaison (MI, WI, MN) Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison. Key aspects of this role will include engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights, serve as a therapeutic expert and thought partner to internal teams, liaison between Revolution Medicines and clinical study sites / investigators, and provide support for medical education, advisory boards, and medical congresses. Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The Lung MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fe67fffa8f0de0487f438e51c90baa42:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.63529583dbd31122c7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fe67fffa8f0de0487f438e51c90baa42:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.fd5325da1f564d2968", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:fe67fffa8f0de0487f438e51c90baa42:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.783905cdee56d58756", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f6a88b5251c4b1b601", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "fe67fffa8f0de0487f438e51c90baa42", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7734111003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "b983ea3a1fb38d8c8284bdecc00d8a23", "title": "Senior Director, Commercial Drug Product Manufacturing Operations", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 244000, "salary_max": 305000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 244000, "base_salary_max": 305000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-10T17:16:33.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Commercial Drug Product Manufacturing Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Commercial Drug Product Manufacturing Operations will lead commercial drug product manufacturing and primary packaging activities within the Drug Product Development & Manufacturing organization. The role will oversee execution of commercial manufacturing operations across external manufacturing and packaging partners to support reliable commercial supply and lifecycle management. Responsibilities include commercial readiness activities, site qualification, technology transfer, process validation, PPQ execution, post-approval changes, troubleshooting, continued process verification (CPV), and operational excellence initiatives. The role will also support execution of commercial process monitoring activities to ensure sustained process performance and product quality. Responsibilities: - Lead execution of commercial manufacturing and primary packaging operations across CMOs and packaging partners. - Lead implementation of post-approval manufacturing and packaging changes. - Lead execution of continued process verification (CPV) activities across commercial manufacturing operations. - Manage monitoring and trending of critical process parameters, process", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 15, "years_experience_max": null, "role_function": "product", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4edfd71f0ab5f92b9e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "b983ea3a1fb38d8c8284bdecc00d8a23", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c57f2062a292d37279", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "b983ea3a1fb38d8c8284bdecc00d8a23", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.6dd14d13d6b5ec4897", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "b983ea3a1fb38d8c8284bdecc00d8a23", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "product", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:b983ea3a1fb38d8c8284bdecc00d8a23:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7757586003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "7612e2f28c08ff598fb9812047c51482", "title": "Senior Scientist I, Clinical Biomarker Development", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 149000, "salary_max": 186000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 149000, "base_salary_max": 186000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:43:56.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7695669003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Scientist I, Clinical Biomarker Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Scientist I in Clinical Biomarker Development team, within the Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine's oncology pipeline. You will: - Design and execute clinical biomarker strategies to support early response monitoring, patient stratification, and understanding resistance mechanisms. - Support biomarker implementation for early- and late-stage oncology clinical trials. - Oversee biomarker assay development, qualification, and sample analysis in collaboration with internal teams and external CROs. - Analyze and interpret biomarker data in the context of clinical outcomes and present results to cross-functional teams. - Contribute to clinical protocols, study reports, and regulatory documents (e.g., INDs, IBs, CSRs). - Translate preclinical findings into clinically actionable biomarker hypotheses. - Stay current with emerging biomarker technologies and trends in precision oncology. Required Skills, Experience and Education: - PhD", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 9, "role_function": "data", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.6e961d0c06edd1d80f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7612e2f28c08ff598fb9812047c51482", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Scientist I, Clinical Biomarker Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Scientist I in Clinical Biomarker Development team, within the Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine's oncology pipeline. You will: - Design and execute clinical biomarker strategies to support early response monitoring, patient stratification, and understanding resistance mechanisms. - Support biomarker implementation for early- and late-stage oncology clinical trials. - Oversee biomarker assay development, qualification, and sample analysis in collaboration with internal teams and external CROs. - Analyze and interpret biomarker data in the context of clinical outcomes and present results to cross-functional teams. - Contribute to clinical protocols, study reports, and regulatory documents (e.g., INDs, IBs, CSRs). - Translate preclinical findings into clinically actionable biomarker hypotheses. - Stay current with emerging biomarker technologies and trends in precision oncology. Required Skills, Experience and Education: - PhD", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:7612e2f28c08ff598fb9812047c51482:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.bfa18b954c33e75727", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7612e2f28c08ff598fb9812047c51482", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Scientist I, Clinical Biomarker Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Scientist I in Clinical Biomarker Development team, within the Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine's oncology pipeline. You will: - Design and execute clinical biomarker strategies to support early response monitoring, patient stratification, and understanding resistance mechanisms. - Support biomarker implementation for early- and late-stage oncology clinical trials. - Oversee biomarker assay development, qualification, and sample analysis in collaboration with internal teams and external CROs. - Analyze and interpret biomarker data in the context of clinical outcomes and present results to cross-functional teams. - Contribute to clinical protocols, study reports, and regulatory documents (e.g., INDs, IBs, CSRs). - Translate preclinical findings into clinically actionable biomarker hypotheses. - Stay current with emerging biomarker technologies and trends in precision oncology. Required Skills, Experience and Education: - PhD", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:7612e2f28c08ff598fb9812047c51482:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1f2613b730ac169cd9", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7612e2f28c08ff598fb9812047c51482", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:7612e2f28c08ff598fb9812047c51482:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f4cd0f8911b1dcdf5f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7612e2f28c08ff598fb9812047c51482", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:7612e2f28c08ff598fb9812047c51482:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.205036a59d7e397f6a", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7612e2f28c08ff598fb9812047c51482", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8f600aa76615435b4f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "7612e2f28c08ff598fb9812047c51482", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695669003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695669003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695669003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695669003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695669003", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "85f7f5d0e79fde4085f96025ec99c55c", "title": "Senior Medical Director - Late Phase", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 346000, "salary_max": 397000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 346000, "base_salary_max": 397000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T21:30:29.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7697171003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Medical Director - Late Phase Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an experienced clinical science drug developer to serve as Senior Medical Director in support of Revolution Medicines' clinical-stage molecule(s). In this critical role, you will support various clinical science deliverables and enable effective and efficient execution of the clinical development plan for a molecule(s) within its particular indication(s). The physician-scientist will focus on ensuring the accuracy, completeness, and integrity of clinical data supporting regulatory submissions (NDA, BLA, MAA). This role is uniquely positioned at the interface of clinical development, regulatory science, clinical data, and clinical operations, and will be instrumental in preparing pivotal datasets from the pivotal and supportive studies for successful global filings. The ideal candidate brings a strong foundation in clinical medicine (M.D. or equivalent), oncology experience, and proven expertise in clinical trial data review, cleaning, and regulatory submission preparation. The scope of data review and", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 13, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.10b445406c07b904b0", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "85f7f5d0e79fde4085f96025ec99c55c", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Medical Director - Late Phase Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an experienced clinical science drug developer to serve as Senior Medical Director in support of Revolution Medicines' clinical-stage molecule(s). In this critical role, you will support various clinical science deliverables and enable effective and efficient execution of the clinical development plan for a molecule(s) within its particular indication(s). The physician-scientist will focus on ensuring the accuracy, completeness, and integrity of clinical data supporting regulatory submissions (NDA, BLA, MAA). This role is uniquely positioned at the interface of clinical development, regulatory science, clinical data, and clinical operations, and will be instrumental in preparing pivotal datasets from the pivotal and supportive studies for successful global filings. The ideal candidate brings a strong foundation in clinical medicine (M.D. or equivalent), oncology experience, and proven expertise in clinical trial data review, cleaning, and regulatory submission preparation. The scope of data review and", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:85f7f5d0e79fde4085f96025ec99c55c:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.41a1dc1359141bc4be", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "85f7f5d0e79fde4085f96025ec99c55c", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Medical Director - Late Phase Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an experienced clinical science drug developer to serve as Senior Medical Director in support of Revolution Medicines' clinical-stage molecule(s). In this critical role, you will support various clinical science deliverables and enable effective and efficient execution of the clinical development plan for a molecule(s) within its particular indication(s). The physician-scientist will focus on ensuring the accuracy, completeness, and integrity of clinical data supporting regulatory submissions (NDA, BLA, MAA). This role is uniquely positioned at the interface of clinical development, regulatory science, clinical data, and clinical operations, and will be instrumental in preparing pivotal datasets from the pivotal and supportive studies for successful global filings. The ideal candidate brings a strong foundation in clinical medicine (M.D. or equivalent), oncology experience, and proven expertise in clinical trial data review, cleaning, and regulatory submission preparation. The scope of data review and", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:85f7f5d0e79fde4085f96025ec99c55c:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.060c63825e046e5982", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "85f7f5d0e79fde4085f96025ec99c55c", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:85f7f5d0e79fde4085f96025ec99c55c:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9944660f8c83ae1708", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "85f7f5d0e79fde4085f96025ec99c55c", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:85f7f5d0e79fde4085f96025ec99c55c:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1af5af9748ada6e709", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "85f7f5d0e79fde4085f96025ec99c55c", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2b3a37eec000015fc4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "85f7f5d0e79fde4085f96025ec99c55c", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697171003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697171003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697171003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697171003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697171003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "24aa8ed83f53570e62d124da4cf36f50", "title": "Associate Director, Tax", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 186000, "salary_max": 233000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 186000, "base_salary_max": 233000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-12T23:36:15.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7732675003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Tax Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated individual with a tax background to play a critical role as a Associate Director of Tax within the finance department. Partnering with the Senior Director of Tax and finance team, the Associate Director will support global tax strategy, provision, and compliance, acting as a key cross-functional collaborative partner with R&D, international, and commercial teams to achieve business goals and meet the financial obligations of the organization. The role is an individual contributor reporting to the Senior Director of Tax and will work closely with external tax advisors, auditors, and internal stakeholders. Current tax department of two, with the possibility of expanding the team as the company advances. Responsibilities include: - Assist in the management and development of Company's international, US and state tax strategy. - Assist with and/or drive the research of complex tax technical topics, ultimately positioning", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": null, "role_function": "finance", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.226c12c3d76ad6ac49", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24aa8ed83f53570e62d124da4cf36f50", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Tax Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated individual with a tax background to play a critical role as a Associate Director of Tax within the finance department. Partnering with the Senior Director of Tax and finance team, the Associate Director will support global tax strategy, provision, and compliance, acting as a key cross-functional collaborative partner with R&D, international, and commercial teams to achieve business goals and meet the financial obligations of the organization. The role is an individual contributor reporting to the Senior Director of Tax and will work closely with external tax advisors, auditors, and internal stakeholders. Current tax department of two, with the possibility of expanding the team as the company advances. Responsibilities include: - Assist in the management and development of Company's international, US and state tax strategy. - Assist with and/or drive the research of complex tax technical topics, ultimately positioning", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:24aa8ed83f53570e62d124da4cf36f50:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.97b156b26fc5742a0e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24aa8ed83f53570e62d124da4cf36f50", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Tax Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a motivated individual with a tax background to play a critical role as a Associate Director of Tax within the finance department. Partnering with the Senior Director of Tax and finance team, the Associate Director will support global tax strategy, provision, and compliance, acting as a key cross-functional collaborative partner with R&D, international, and commercial teams to achieve business goals and meet the financial obligations of the organization. The role is an individual contributor reporting to the Senior Director of Tax and will work closely with external tax advisors, auditors, and internal stakeholders. Current tax department of two, with the possibility of expanding the team as the company advances. Responsibilities include: - Assist in the management and development of Company's international, US and state tax strategy. - Assist with and/or drive the research of complex tax technical topics, ultimately positioning", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:24aa8ed83f53570e62d124da4cf36f50:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.94127ccb5e6302ad94", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24aa8ed83f53570e62d124da4cf36f50", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:24aa8ed83f53570e62d124da4cf36f50:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d4c8286458ca831462", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24aa8ed83f53570e62d124da4cf36f50", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:24aa8ed83f53570e62d124da4cf36f50:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6aae16407f589a5d70", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24aa8ed83f53570e62d124da4cf36f50", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6e009464bf2b54c2af", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "24aa8ed83f53570e62d124da4cf36f50", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7732675003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7732675003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7732675003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7732675003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7732675003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7732675003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "781d0bb22af5a52255b78b7d2afa66d0", "title": "Scientist II, DMPK", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 132000, "salary_max": 166000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 132000, "base_salary_max": 166000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T22:59:17.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7695463003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Scientist II, DMPK Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The DMPK Scientist will be a key member of the Drug Metabolism and Pharmacokinetics (DMPK) team within the Nonclinical Development and Clinical Pharmacology (NDCP) department. Specifically, you will: - Design and execute in vitro and in vivo metabolite identification studies using liver microsomes, hepatocytes, recombinant enzymes, and biological samples (blood, plasma, tissue, urine, bile, etc.), and perform metabolite profiling and structural elucidation. - Characterize major, unique, or disproportionate metabolites to support candidate selection, MIST (Metabolites in Safety Testing) analysis, and metabolite regulatory strategy. - Design and perform mechanistic studies to understand metabolic pathways and enzyme kinetics; work with pharmaceutical product teams to characterize drug degradation products and impurities. - Author and review DMPK sections of regulatory submissions and respond to questions from regulatory agencies. - Build and maintain strong collaborative partnerships across functional areas, e.g., Discovery research, Clinical Pharmacology, Medicinal Chemistry, Pharmaceutical Development, Toxicology,", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 2, "years_experience_max": 9, "role_function": "other", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.be1ea3b68939862f7d", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "781d0bb22af5a52255b78b7d2afa66d0", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f3c56e3031505a0d91", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "781d0bb22af5a52255b78b7d2afa66d0", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.fa269a4125c54f039b", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "781d0bb22af5a52255b78b7d2afa66d0", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "other", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:781d0bb22af5a52255b78b7d2afa66d0:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695463003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695463003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695463003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695463003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695463003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "09b88e3020a9f41df9c4a1c348c51632", "title": "Senior Manager, Marketing, Lung", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 150000, "salary_max": 189000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 150000, "base_salary_max": 189000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-09T22:24:32.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7767420003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Manager, Marketing, Lung Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Senior Marketing Manager, you will be a key contributor to the development of compelling omnichannel campaigns that promote Revolution Medicine's values, scientific innovation, and patient centricity. You will develop and execute marketing strategies and plans to achieve brand objectives and growth targets, particularly for non-personal promotion initiatives. Identification and implementation of innovative digital promotion technologies will be essential to this role. You will also collaborate cross-functionally and support media planning, campaign measurement, campaign asset promotional review, and related expense budgets. - Engages in strategic market planning through developing and executing marketing strategies for lung cancer products and indications. - Understands customer needs and preferences to create engaging and effective marketing campaigns. - Oversees the execution of marketing campaigns across various channels, including digital, print, and field-based resources. - Tracks and analyzes marketing campaign performance to identify areas for improvement and provide recommendations for", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 9, "role_function": "marketing", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.b02d9347b5a709c9c9", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "09b88e3020a9f41df9c4a1c348c51632", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Marketing, Lung Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Senior Marketing Manager, you will be a key contributor to the development of compelling omnichannel campaigns that promote Revolution Medicine's values, scientific innovation, and patient centricity. You will develop and execute marketing strategies and plans to achieve brand objectives and growth targets, particularly for non-personal promotion initiatives. Identification and implementation of innovative digital promotion technologies will be essential to this role. You will also collaborate cross-functionally and support media planning, campaign measurement, campaign asset promotional review, and related expense budgets. - Engages in strategic market planning through developing and executing marketing strategies for lung cancer products and indications. - Understands customer needs and preferences to create engaging and effective marketing campaigns. - Oversees the execution of marketing campaigns across various channels, including digital, print, and field-based resources. - Tracks and analyzes marketing campaign performance to identify areas for improvement and provide recommendations for", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:09b88e3020a9f41df9c4a1c348c51632:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e283e81288f7b68de8", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "09b88e3020a9f41df9c4a1c348c51632", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Marketing, Lung Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Senior Marketing Manager, you will be a key contributor to the development of compelling omnichannel campaigns that promote Revolution Medicine's values, scientific innovation, and patient centricity. You will develop and execute marketing strategies and plans to achieve brand objectives and growth targets, particularly for non-personal promotion initiatives. Identification and implementation of innovative digital promotion technologies will be essential to this role. You will also collaborate cross-functionally and support media planning, campaign measurement, campaign asset promotional review, and related expense budgets. - Engages in strategic market planning through developing and executing marketing strategies for lung cancer products and indications. - Understands customer needs and preferences to create engaging and effective marketing campaigns. - Oversees the execution of marketing campaigns across various channels, including digital, print, and field-based resources. - Tracks and analyzes marketing campaign performance to identify areas for improvement and provide recommendations for", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:09b88e3020a9f41df9c4a1c348c51632:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0c9c2212c458cd6883", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "09b88e3020a9f41df9c4a1c348c51632", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:09b88e3020a9f41df9c4a1c348c51632:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.31d9d438c8db58933c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "09b88e3020a9f41df9c4a1c348c51632", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:09b88e3020a9f41df9c4a1c348c51632:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1375a3ebf13058f159", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "09b88e3020a9f41df9c4a1c348c51632", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e925219a2d77767469", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "09b88e3020a9f41df9c4a1c348c51632", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767420003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767420003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767420003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767420003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767420003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767420003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7767420003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "1fbba28a67b6d6b9f5c37572fd732892", "title": "Senior Manager, Global Patient Safety Operations", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 164000, "salary_max": 205000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 164000, "base_salary_max": 205000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-13T19:26:36.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7733787003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Manager, Global Patient Safety Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This position will be responsible for the management, development, and oversight of Global Patient Safety operational activities in the execution of safety information collection and reporting for the assigned Revolution Medicines' clinical programs. - Participates in the development of Global Patient Safety Operations operational objectives, policies, and procedures. - Represent Global Patient Safety in different cross functional team meetings. - Collaborate with other functional groups to achieve clinical program goals. - Oversee Pharmacovigilance Contract Research Organization (PV CRO) in the execution of safety reporting in clinical studies. - Manage PV CROs to ensure compliance with required timelines, that potential issues are being communicated, and resolution is achieved in a timely manner. - Oversee reporting of safety reports to global regulatory authorities, central IRB/ethics committees, investigators to ensure compliance with global regulatory requirements. - Ensure timely and accurate set up of global", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 9, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.ad5569ed60d6356f99", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "1fbba28a67b6d6b9f5c37572fd732892", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Global Patient Safety Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This position will be responsible for the management, development, and oversight of Global Patient Safety operational activities in the execution of safety information collection and reporting for the assigned Revolution Medicines' clinical programs. - Participates in the development of Global Patient Safety Operations operational objectives, policies, and procedures. - Represent Global Patient Safety in different cross functional team meetings. - Collaborate with other functional groups to achieve clinical program goals. - Oversee Pharmacovigilance Contract Research Organization (PV CRO) in the execution of safety reporting in clinical studies. - Manage PV CROs to ensure compliance with required timelines, that potential issues are being communicated, and resolution is achieved in a timely manner. - Oversee reporting of safety reports to global regulatory authorities, central IRB/ethics committees, investigators to ensure compliance with global regulatory requirements. - Ensure timely and accurate set up of global", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:1fbba28a67b6d6b9f5c37572fd732892:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.c92f137ab87cac8f70", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "1fbba28a67b6d6b9f5c37572fd732892", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Global Patient Safety Operations Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This position will be responsible for the management, development, and oversight of Global Patient Safety operational activities in the execution of safety information collection and reporting for the assigned Revolution Medicines' clinical programs. - Participates in the development of Global Patient Safety Operations operational objectives, policies, and procedures. - Represent Global Patient Safety in different cross functional team meetings. - Collaborate with other functional groups to achieve clinical program goals. - Oversee Pharmacovigilance Contract Research Organization (PV CRO) in the execution of safety reporting in clinical studies. - Manage PV CROs to ensure compliance with required timelines, that potential issues are being communicated, and resolution is achieved in a timely manner. - Oversee reporting of safety reports to global regulatory authorities, central IRB/ethics committees, investigators to ensure compliance with global regulatory requirements. - Ensure timely and accurate set up of global", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:1fbba28a67b6d6b9f5c37572fd732892:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.811d802c466ce7b096", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "1fbba28a67b6d6b9f5c37572fd732892", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:1fbba28a67b6d6b9f5c37572fd732892:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.94c7ca33a49b54a0c0", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "1fbba28a67b6d6b9f5c37572fd732892", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:1fbba28a67b6d6b9f5c37572fd732892:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.50b5c649ff2607f57f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "1fbba28a67b6d6b9f5c37572fd732892", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a389686cc8c350ff95", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "1fbba28a67b6d6b9f5c37572fd732892", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7733787003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7733787003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7733787003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7733787003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7733787003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7733787003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "608d83d690717e6e1f00629f6f147ddb", "title": "Scientist I, Quantitative Systems Pharmacologist", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 119000, "salary_max": 149000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 119000, "base_salary_max": 149000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-08T18:03:24.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7727990003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Scientist I, Quantitative Systems Pharmacologist Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a QSP modeling & simulation scientist to be part of the Nonclinical Development and Clinical Pharmacology (NDCP) organization. This position will be responsible for developing, validating, and executing modeling projects with a focus on mechanistic PBPK-QSP mathematical models for small molecule programs to increase mechanistic understanding of compound PK behavior and drug distribution, pharmacological effects on RAS targets, support clinical translation, and drive future discovery and development efforts. As a Quantitative Systems Pharmacologist, you will: - Develop, validate, execute, and refine quantitative systems pharmacology (QSP) models, minimal physiologically based pharmacokinetic (PBPK) models, semi-mechanistic PK/PD models, and tumor growth models to support development and discovery phase projects including next-generation inhibitor design and assessment of combination potential. - Propose and perform in silico simulations to answer complex mechanistic questions, create data visualizations to effectively communicate modeling results to a wide-ranging audience,", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 0, "years_experience_max": 7, "role_function": "data", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.89c21a4afb53f599e8", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "608d83d690717e6e1f00629f6f147ddb", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.bdefb052f12dd359da", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "608d83d690717e6e1f00629f6f147ddb", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.26ba192d1a60f52d37", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "608d83d690717e6e1f00629f6f147ddb", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "data", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:608d83d690717e6e1f00629f6f147ddb:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7727990003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7727990003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7727990003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7727990003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7727990003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7727990003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "e1a992cc483b9b13522173ca69b53f72", "title": "Associate Director, Learning & Engagement", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 186000, "salary_max": 233000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 186000, "base_salary_max": 233000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-27T00:44:35.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7749061003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Learning & Engagement Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This is an exciting opportunity to lead the Learning & Engagement initiatives. The Associate Director, Learning & Engagement will lead the design, development and implementation of learning initiatives, instructional design solutions, learning forums, and infrastructure initiatives across partnered functions and in close alignment with HR and RevMed Learning and Engagement functions' best practices. This role requires a blend of Learning & Development expertise, a solid understanding of drug development processes & skillsets, and the communication abilities to support a diverse portfolio of strategic growth initiatives. Responsibilities: - Lead and deliver innovative learning programs that support the implementation and continuous improvement of DCS Growth & Enablement strategic roadmap and initiatives. - Drive the adoption of new business processes through training, communication, knowledge management, and change management. - Collaborate within Business Operations and across department leaders and functional subject-matter experts to assess training needs,", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": 12, "role_function": "hr", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4195ea2f3c46742b8a", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "e1a992cc483b9b13522173ca69b53f72", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a32aab7290117402c9", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "e1a992cc483b9b13522173ca69b53f72", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.35f68aa8d5bcc9a622", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "e1a992cc483b9b13522173ca69b53f72", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "hr", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:e1a992cc483b9b13522173ca69b53f72:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7749061003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7749061003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7749061003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7749061003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7749061003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7749061003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "2815fcfc85766b82f13cccb673284eb4", "title": "Senior Director, Organizational Development & Effectiveness", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 244000, "salary_max": 305000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 244000, "base_salary_max": 305000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-22T20:05:00.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7711168003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Organizational Development & Effectiveness Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a strategic and enterprise-minded leader to build and scale the Organizational Development and Effectiveness function at Revolution Medicines. As Senior Director, Organizational Effectiveness, you will define and drive the long-term strategy for leadership effectiveness, team performance and organizational health to support our rapid growth and strengthen our mission-driven, values-aligned culture. This role partners closely with HR Business Partners, Learning & Development and Senior Leaders across all functions and regions to deliver high-impact organizational programs and solutions to drive team effectiveness. You will design a scalable, data-informed approach that leverages both internal capabilities and an external network of coaches and facilitators to meet evolving business needs. This function will ensure that leaders and teams are equipped to operate effectively at scale, while providing clear insights and interventions that enhance organizational performance across the enterprise. The function will lead both", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "engineering", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.26b0f232b48801d7ea", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2815fcfc85766b82f13cccb673284eb4", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Organizational Development & Effectiveness Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a strategic and enterprise-minded leader to build and scale the Organizational Development and Effectiveness function at Revolution Medicines. As Senior Director, Organizational Effectiveness, you will define and drive the long-term strategy for leadership effectiveness, team performance and organizational health to support our rapid growth and strengthen our mission-driven, values-aligned culture. This role partners closely with HR Business Partners, Learning & Development and Senior Leaders across all functions and regions to deliver high-impact organizational programs and solutions to drive team effectiveness. You will design a scalable, data-informed approach that leverages both internal capabilities and an external network of coaches and facilitators to meet evolving business needs. This function will ensure that leaders and teams are equipped to operate effectively at scale, while providing clear insights and interventions that enhance organizational performance across the enterprise. The function will lead both", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:2815fcfc85766b82f13cccb673284eb4:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.682029ff2cb47b95f8", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2815fcfc85766b82f13cccb673284eb4", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director, Organizational Development & Effectiveness Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a strategic and enterprise-minded leader to build and scale the Organizational Development and Effectiveness function at Revolution Medicines. As Senior Director, Organizational Effectiveness, you will define and drive the long-term strategy for leadership effectiveness, team performance and organizational health to support our rapid growth and strengthen our mission-driven, values-aligned culture. This role partners closely with HR Business Partners, Learning & Development and Senior Leaders across all functions and regions to deliver high-impact organizational programs and solutions to drive team effectiveness. You will design a scalable, data-informed approach that leverages both internal capabilities and an external network of coaches and facilitators to meet evolving business needs. This function will ensure that leaders and teams are equipped to operate effectively at scale, while providing clear insights and interventions that enhance organizational performance across the enterprise. The function will lead both", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:2815fcfc85766b82f13cccb673284eb4:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8394dd20e75200bc2e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2815fcfc85766b82f13cccb673284eb4", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:2815fcfc85766b82f13cccb673284eb4:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a61def0407ced21607", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2815fcfc85766b82f13cccb673284eb4", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:2815fcfc85766b82f13cccb673284eb4:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.37c33ae356b2faf87b", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2815fcfc85766b82f13cccb673284eb4", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3af3c17a72de79ed5b", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2815fcfc85766b82f13cccb673284eb4", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7711168003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7711168003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7711168003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7711168003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7711168003", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "2e0b768069ba4742703680f3b1bab161", "title": "Vice President Sales and Field Team - NSCLC", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (United States)", "country": "US", "employment_type": "full_time", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": 294000, "salary_max": 367000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 294000, "base_salary_max": 367000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-29T21:58:32.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7719965003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Vice President Sales and Field Team - NSCLC Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Vice President, Oncology Sales will lead the design, build, and execution of a high-performing, national oncology sales organization supporting Revolution Medicines products/services to the oncology communityg. Reporting to the SVP of US Marketing & Sales, the VP will be responsible for creating and scaling a best-in-class sales organization, ensuring successful product launches, and driving sustained revenue growth. This leader will combine strategic vision with operational rigor, leveraging deep oncology expertise and cross-functional collaboration to position the organization for long-term success. Key Responsibilities: Organizational Build & Leadership - Architect and execute the build-out of a national oncology sales organization, including hiring, onboarding, and development of regional leaders, account directors, and sales representatives. - This will include nurse educator and other field facing roles or functions including sales operations and training. - Establish organizational structure, roles, and deployment strategy aligned to brand", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 52, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "sales", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 50, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.3a1fbda9da58c7d8dd", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2e0b768069ba4742703680f3b1bab161", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Vice President Sales and Field Team - NSCLC Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Vice President, Oncology Sales will lead the design, build, and execution of a high-performing, national oncology sales organization supporting Revolution Medicines products/services to the oncology communityg. Reporting to the SVP of US Marketing & Sales, the VP will be responsible for creating and scaling a best-in-class sales organization, ensuring successful product launches, and driving sustained revenue growth. This leader will combine strategic vision with operational rigor, leveraging deep oncology expertise and cross-functional collaboration to position the organization for long-term success. Key Responsibilities: Organizational Build & Leadership - Architect and execute the build-out of a national oncology sales organization, including hiring, onboarding, and development of regional leaders, account directors, and sales representatives. - This will include nurse educator and other field facing roles or functions including sales operations and training. - Establish organizational structure, roles, and deployment strategy aligned to brand", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:2e0b768069ba4742703680f3b1bab161:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.bcb52ad98fafe82772", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2e0b768069ba4742703680f3b1bab161", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Vice President Sales and Field Team - NSCLC Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Vice President, Oncology Sales will lead the design, build, and execution of a high-performing, national oncology sales organization supporting Revolution Medicines products/services to the oncology communityg. Reporting to the SVP of US Marketing & Sales, the VP will be responsible for creating and scaling a best-in-class sales organization, ensuring successful product launches, and driving sustained revenue growth. This leader will combine strategic vision with operational rigor, leveraging deep oncology expertise and cross-functional collaboration to position the organization for long-term success. Key Responsibilities: Organizational Build & Leadership - Architect and execute the build-out of a national oncology sales organization, including hiring, onboarding, and development of regional leaders, account directors, and sales representatives. - This will include nurse educator and other field facing roles or functions including sales operations and training. - Establish organizational structure, roles, and deployment strategy aligned to brand", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:2e0b768069ba4742703680f3b1bab161:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.211251565d767449c0", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2e0b768069ba4742703680f3b1bab161", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:2e0b768069ba4742703680f3b1bab161:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7cf103b99a935233f2", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2e0b768069ba4742703680f3b1bab161", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:2e0b768069ba4742703680f3b1bab161:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3a3062c304565b7135", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2e0b768069ba4742703680f3b1bab161", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7fe1f716d98ac8ea1b", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "2e0b768069ba4742703680f3b1bab161", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7719965003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7719965003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7719965003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7719965003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7719965003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7719965003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7719965003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "12b9611162f7c5c6fb073f3594ec2fdd", "title": "Senior Director, Medical Affairs, France", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Paris, France", "country": "FR", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 3, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "UNSPECIFIED", "salary_type": "unknown", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-28T21:54:12.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7717880003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director, Medical Affairs, France Paris, France Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the VP, General Manager, France the Senior Director, Medical Affairs, France is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the French Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. This leader will ensure that French medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the French medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions. Responsibilities: - Act as the Medical Affairs lead for France, accountable for local medical strategy, execution, and impact", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 40, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "healthcare", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 45, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a67f1aecfd29a32043", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "12b9611162f7c5c6fb073f3594ec2fdd", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.efc87f21030d8e98b4", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "12b9611162f7c5c6fb073f3594ec2fdd", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.b20cdeeefa6dd63f2f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "12b9611162f7c5c6fb073f3594ec2fdd", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:12b9611162f7c5c6fb073f3594ec2fdd:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7717880003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7717880003", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "3971021563453976eb0aa6df2105be1c", "title": "Associate Director, Accounting - Japan", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Remote (Japan)", "country": "JP", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 3, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "UNSPECIFIED", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-21T01:19:37.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7742334003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Accounting - Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking an experienced, strategic, and hands-on accounting leader to build and scale the accounting and finance operations infrastructure in Japan. Reporting directly to the Head of Finance & Operations, Japan, this newly created role will play a critical role in supporting the company's transition toward future commercial readiness and long-term growth in Japan. This position will lead core accounting operations, financial systems implementation, process design, internal controls, and statutory compliance, while partnering cross-functionally to establish a scalable and compliant finance environment capable of supporting a commercial-stage organization. The role will also serve as a key business partner across Finance, Commercial, Legal, Supply Chain, HR, and global teams to help prepare the organization for future product launches and increasing operational complexity. The ideal candidate combines strong technical accounting expertise with operational leadership, systems implementation experience, and the ability to build processes and infrastructure", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 48, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": 12, "role_function": "finance", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 45, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.cf937ace88013f0af7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3971021563453976eb0aa6df2105be1c", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Accounting - Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking an experienced, strategic, and hands-on accounting leader to build and scale the accounting and finance operations infrastructure in Japan. Reporting directly to the Head of Finance & Operations, Japan, this newly created role will play a critical role in supporting the company's transition toward future commercial readiness and long-term growth in Japan. This position will lead core accounting operations, financial systems implementation, process design, internal controls, and statutory compliance, while partnering cross-functionally to establish a scalable and compliant finance environment capable of supporting a commercial-stage organization. The role will also serve as a key business partner across Finance, Commercial, Legal, Supply Chain, HR, and global teams to help prepare the organization for future product launches and increasing operational complexity. The ideal candidate combines strong technical accounting expertise with operational leadership, systems implementation experience, and the ability to build processes and infrastructure", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3971021563453976eb0aa6df2105be1c:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.d2ee792fc1d64f0084", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3971021563453976eb0aa6df2105be1c", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Accounting - Japan Remote (Japan) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking an experienced, strategic, and hands-on accounting leader to build and scale the accounting and finance operations infrastructure in Japan. Reporting directly to the Head of Finance & Operations, Japan, this newly created role will play a critical role in supporting the company's transition toward future commercial readiness and long-term growth in Japan. This position will lead core accounting operations, financial systems implementation, process design, internal controls, and statutory compliance, while partnering cross-functionally to establish a scalable and compliant finance environment capable of supporting a commercial-stage organization. The role will also serve as a key business partner across Finance, Commercial, Legal, Supply Chain, HR, and global teams to help prepare the organization for future product launches and increasing operational complexity. The ideal candidate combines strong technical accounting expertise with operational leadership, systems implementation experience, and the ability to build processes and infrastructure", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3971021563453976eb0aa6df2105be1c:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a4ee9fc81bb81aeaeb", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3971021563453976eb0aa6df2105be1c", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3971021563453976eb0aa6df2105be1c:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b17864c11305eda573", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3971021563453976eb0aa6df2105be1c", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:3971021563453976eb0aa6df2105be1c:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4a81f6fc571d20899c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3971021563453976eb0aa6df2105be1c", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9036c5952e978d188f", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "3971021563453976eb0aa6df2105be1c", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742334003", "source_values": [ "rule:remote_status" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742334003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742334003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742334003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "6448796982e8f48d09c86705f4f34d85", "title": "Principal Product Manager, Clinical Trials Intelligence", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 186000, "salary_max": 233000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 186000, "base_salary_max": 233000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-19T06:12:49.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7739001003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Principal Product Manager, Clinical Trials Intelligence Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Principal Product Manager, Clinical Trials Intelligence to build products that help teams plan, run, monitor, analyze, submit, and follow clinical trials with greater speed, quality, and confidence.This role will define and deliver product strategy across the clinical trial continuum, from study design and startup through trial conduct, submission readiness, and post-approval safety monitoring. You will shape Clinical Trials Intelligence capabilities on RevCore, our enterprise data and AI platform, with a clear mandate to improve trial execution, enrollment predictability, data readiness, submission readiness, inspection readiness, and safety monitoring. You will work on high-stakes products where trust, usability, traceability, and speed directly affect trial execution, regulatory readiness, and patient impact. This role focuses on product strategy, user outcomes, workflow design, adoption, and measurable impact, in partnership with clinical, regulatory, safety, medical, data, technology, quality, vendor, and system owner teams.", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "principal", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 12, "years_experience_max": null, "role_function": "product", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0be8f9d77938351028", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6448796982e8f48d09c86705f4f34d85", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.cfcb70baa803ca441a", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6448796982e8f48d09c86705f4f34d85", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.c7b3951f3de20c276e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6448796982e8f48d09c86705f4f34d85", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "product", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:6448796982e8f48d09c86705f4f34d85:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739001003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739001003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739001003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739001003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739001003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7739001003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "43964159ee60577e46c710082caa2193", "title": "Executive Director, Global Scientific Communications", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 265000, "salary_max": 331000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 265000, "base_salary_max": 331000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-11T23:05:00.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7731549003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Executive Director, Global Scientific Communications Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a new member of the Revolution Medicines team, the Executive Director, Global Scientific Communications will lead the development and execution of a comprehensive scientific communications strategy and team, ensuring alignment across internal and external stakeholders in preparation for the company's first commercial launch in pancreatic cancer and the progression of additional pipeline assets in NSCLC, colorectal cancer, and other solid tumors. Reporting into the SVP, Global Medical Affairs, this role will will be responsible for leading our scientific communications platforms and publication strategies and contribute to medical content supporting the organization's medical and scientific engagement efforts. Key responsibilities include: Publications Strategy & Execution - Lead the development and execution of the global publication plans, ensuring alignment with clinical and scientific objectives. - Oversee and provide strategic direction for medical writing, publication planning meetings, the submission process, and timely/high-quality scientific communications and", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 15, "years_experience_max": null, "role_function": "marketing", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.b82e41b05bc00bbdfb", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "43964159ee60577e46c710082caa2193", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Executive Director, Global Scientific Communications Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a new member of the Revolution Medicines team, the Executive Director, Global Scientific Communications will lead the development and execution of a comprehensive scientific communications strategy and team, ensuring alignment across internal and external stakeholders in preparation for the company's first commercial launch in pancreatic cancer and the progression of additional pipeline assets in NSCLC, colorectal cancer, and other solid tumors. Reporting into the SVP, Global Medical Affairs, this role will will be responsible for leading our scientific communications platforms and publication strategies and contribute to medical content supporting the organization's medical and scientific engagement efforts. Key responsibilities include: Publications Strategy & Execution - Lead the development and execution of the global publication plans, ensuring alignment with clinical and scientific objectives. - Oversee and provide strategic direction for medical writing, publication planning meetings, the submission process, and timely/high-quality scientific communications and", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:43964159ee60577e46c710082caa2193:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e2f681bb1de293c193", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "43964159ee60577e46c710082caa2193", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Executive Director, Global Scientific Communications Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a new member of the Revolution Medicines team, the Executive Director, Global Scientific Communications will lead the development and execution of a comprehensive scientific communications strategy and team, ensuring alignment across internal and external stakeholders in preparation for the company's first commercial launch in pancreatic cancer and the progression of additional pipeline assets in NSCLC, colorectal cancer, and other solid tumors. Reporting into the SVP, Global Medical Affairs, this role will will be responsible for leading our scientific communications platforms and publication strategies and contribute to medical content supporting the organization's medical and scientific engagement efforts. Key responsibilities include: Publications Strategy & Execution - Lead the development and execution of the global publication plans, ensuring alignment with clinical and scientific objectives. - Oversee and provide strategic direction for medical writing, publication planning meetings, the submission process, and timely/high-quality scientific communications and", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:43964159ee60577e46c710082caa2193:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.42e0719c7e02d13c05", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "43964159ee60577e46c710082caa2193", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:43964159ee60577e46c710082caa2193:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7192c02062750e170e", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "43964159ee60577e46c710082caa2193", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:43964159ee60577e46c710082caa2193:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0fb401c1060201b389", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "43964159ee60577e46c710082caa2193", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.5a6462509ff48681f7", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "43964159ee60577e46c710082caa2193", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7731549003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7731549003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7731549003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7731549003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7731549003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7731549003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "a8e5825c574c5841420c84c59b7beece", "title": "Associate Director, Regulatory Systems", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 186000, "salary_max": 233000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 186000, "base_salary_max": 233000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-20T22:42:55.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7742279003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Regulatory Systems Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Regulatory Business Systems will lead the strategy, governance, implementation, and optimization of Regulatory Affairs technology platforms that support global regulatory operations and submission activities. This individual will serve as the business owner for key regulatory systems and partner closely with Regulatory Affairs, Regulatory Operations, IT, Quality, Clinical, and external vendors to deliver scalable, compliant, and efficient business solutions. The ideal candidate brings deep expertise in regulatory processes, business systems management, and cross-functional collaboration within a biotechnology or pharmaceutical environment. This role will play a critical part in advancing RevMed's regulatory systems roadmap and enabling operational excellence across the regulatory organization. Key Responsibilities: - Serve as the business owner and strategic lead for Regulatory Affairs systems, including Veeva RIM, Veeva Registrations, DocuBridge, and related regulatory platforms. - Drive the long-term strategy, roadmap, and governance model for regulatory business systems aligned with", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": null, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8a6c93d7c0f35d8e23", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a8e5825c574c5841420c84c59b7beece", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b25cd869b41c6eda76", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a8e5825c574c5841420c84c59b7beece", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.2999eeaeb87885de41", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "a8e5825c574c5841420c84c59b7beece", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:a8e5825c574c5841420c84c59b7beece:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742279003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742279003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742279003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742279003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742279003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7742279003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "6666677ea3088b5f8c248db536c3bb91", "title": "Senior Manager, Commercial Regulatory Affairs", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 164000, "salary_max": 205000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 164000, "base_salary_max": 205000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-10T22:15:05.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7695672003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Manager, Commercial Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Senior Manager, Commercial Regulatory Affairs to partner closely with the cross-functional teams to ensure that all promotional and medical communication strategies are compliant with applicable regulations, industry standards, and internal policies. This role will help enable successful product commercialization while upholding regulatory integrity and scientific accuracy. As part of the Regulatory Affairs function, the Senior Manager will work under supervision to provide strategic regulatory advice on advertising/promotion and medical materials to the US organization for assigned products in accordance with business goals and objectives, FDA regulations/guidances, pharma guidelines, and company policy. The position can be based at our Redwood City, CA site in a hybrid work schedule (preferred) or remote-based with quarterly and as needed travel. Required Skills, Experience and Education: - Serves as a primary or secondary regulatory advertising and promotion reviewer for assigned products on", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": 14, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "late-stage", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.2e3cfb68227658d880", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6666677ea3088b5f8c248db536c3bb91", "signal_type": "query_match", "display_text": "Description: \"medicines\"", "tooltip": "Description matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Commercial Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Senior Manager, Commercial Regulatory Affairs to partner closely with the cross-functional teams to ensure that all promotional and medical communication strategies are compliant with applicable regulations, industry standards, and internal policies. This role will help enable successful product commercialization while upholding regulatory integrity and scientific accuracy. As part of the Regulatory Affairs function, the Senior Manager will work under supervision to provide strategic regulatory advice on advertising/promotion and medical materials to the US organization for assigned products in accordance with business goals and objectives, FDA regulations/guidances, pharma guidelines, and company policy. The position can be based at our Redwood City, CA site in a hybrid work schedule (preferred) or remote-based with quarterly and as needed travel. Required Skills, Experience and Education: - Serves as a primary or secondary regulatory advertising and promotion reviewer for assigned products on", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:6666677ea3088b5f8c248db536c3bb91:description:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.fd80a4024362a235af", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6666677ea3088b5f8c248db536c3bb91", "signal_type": "query_match", "display_text": "Description: \"revolution\"", "tooltip": "Description matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Commercial Regulatory Affairs Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Senior Manager, Commercial Regulatory Affairs to partner closely with the cross-functional teams to ensure that all promotional and medical communication strategies are compliant with applicable regulations, industry standards, and internal policies. This role will help enable successful product commercialization while upholding regulatory integrity and scientific accuracy. As part of the Regulatory Affairs function, the Senior Manager will work under supervision to provide strategic regulatory advice on advertising/promotion and medical materials to the US organization for assigned products in accordance with business goals and objectives, FDA regulations/guidances, pharma guidelines, and company policy. The position can be based at our Redwood City, CA site in a hybrid work schedule (preferred) or remote-based with quarterly and as needed travel. Required Skills, Experience and Education: - Serves as a primary or secondary regulatory advertising and promotion reviewer for assigned products on", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:6666677ea3088b5f8c248db536c3bb91:description:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d2da1702acc859cadc", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6666677ea3088b5f8c248db536c3bb91", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer matched \"medicines\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:6666677ea3088b5f8c248db536c3bb91:employer:medicines", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f6073d19e9ef12ef51", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6666677ea3088b5f8c248db536c3bb91", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer matched \"revolution\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:6666677ea3088b5f8c248db536c3bb91:employer:revolution", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.01129969d5ff7de18c", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6666677ea3088b5f8c248db536c3bb91", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d74152943ff18afe51", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "6666677ea3088b5f8c248db536c3bb91", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695672003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695672003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695672003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695672003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695672003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7695672003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "beec845ca71706afe71ef50bf5b2b05a", "title": "Vice President, Patents", "employer_name": "Revolution Medicines", "employer_slug": "revolution-medicines", "location_text": "Redwood City, California, United States", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 354000, "salary_max": 408000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 354000, "base_salary_max": 408000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-11T00:50:31.000Z", "apply_url": "https://www.revmed.com/careers-list/?gh_jid=7697205003", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Vice President, Patents Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an accomplished and highly strategic patent attorney to lead intellectual property strategy for our patent portfolio. This role is designed for a senior expert who can operate at the intersection of sophisticated patent prosecution and patent disputes within one of the most competitive areas in oncology. Reporting to the VP of IP, this individual will serve as our patent portfolio lead, with responsibility for developing and integrating global prosecution and challenge (both offensive and defensive) strategies. The role will function as a key strategic partner to the VP and a trusted advisor to senior leadership, with a primary focus on strengthening the durability and value of company assets worldwide, anticipating competitive threats, and identifying and mitigating vulnerabilities. This position may include management responsibility for members of the IP team, such as those handling patent prosecution. However, people management is not required", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "contractor_type": { "field": "contractor_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "contractor_type" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "legal", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0b3a51733374d3f190", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "beec845ca71706afe71ef50bf5b2b05a", "signal_type": "query_match", "display_text": "Employer: \"revolution\"", "tooltip": "Employer contains \"revolution\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "revolution", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d73bdc073a18fd75b5", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "beec845ca71706afe71ef50bf5b2b05a", "signal_type": "query_match", "display_text": "Employer: \"medicines\"", "tooltip": "Employer contains \"medicines\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Revolution Medicines", "matched_input": "medicines", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.a500e3e5804aeb1b72", "query_id": "gq_c6c74f8a7e63af630381", "job_id": "beec845ca71706afe71ef50bf5b2b05a", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "legal", "matched_input": "revolution medicines", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_c6c74f8a7e63af630381:beec845ca71706afe71ef50bf5b2b05a:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697205003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697205003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697205003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1628171/000119312526071563/rvmd-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697205003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://www.revmed.com/careers-list/?gh_jid=7697205003", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } } ], "total": 199, "page": 3, "per_page": 24, "applied_filters": { "q": "Revolution Medicines" }, "hidden_unknown_benefits_count": 0, "hidden_quality_floor_count": 0, "quality_floor": "default", "search_profile": { "profile_id": "inv382.d6.pg_textsearch_bge_small_rrf.v1", "bm25_extension": "pg_textsearch", "vector_model": "BAAI/bge-small-en-v1.5", "vector_model_version": "v1.5", "fusion_method": "rrf" }, "explanation_context": { "non_trivial_query": true, "query_terms": [ "revolution", "medicines" ], "active_filter_keys": [], "visible_signal_limit": 3, "visible_trust_limit": 2 }, "event_context": { "query_context": { "query_id": "46dbe678-50a4-401e-a0f3-680cf7b39692", "issued_at": "2026-08-13T02:24:13.913Z", "route": "/jobs", "page": 3, "per_page": 24, "total_results": 199, "sort": "relevance", "ranking_policy": "hybrid_rrf_rerank", "ranking_policy_version": "inv382.jobs.search.v2", "query_hash": "hmac_sha256:OdtlEs6N_GFMGtR5mDTNg_XhKGC5gY4zTKwsBLXzhFs", "filter_hash": "hmac_sha256:6CBErDPXOFVCSNkSGbTmuw6GxoMjwSLro0KqZMtxL_0", "query_features": { "has_q": true, "q_term_count": 2, "q_length_bucket": "16_40", "q_pii_redacted": false, "state_count": 0, "benefit_filters": [], "quality_floor": "default" }, "exposures": [ { "result_id": "d005a44c3b8ab85213b5e3db8e22185e", "position": 49, "page_position": 1, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2932748794555664, "rrf_score": 0.01282051282051282, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 124, "quality_score": 55 } }, { "result_id": "c105e3535b716e6f76407b9a11159eb9", "position": 50, "page_position": 2, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.0125, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 64, "quality_score": 45 } }, { "result_id": "93a9f546df4ddd1ef76b292d6ece1c4e", "position": 51, "page_position": 3, "retrieval_features": { "bm25_score": 0, "vector_score": 0.293540877488798, "rrf_score": 0.012345679012345678, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 124, "quality_score": 55 } }, { "result_id": "f106c4f2159a0f9119e40bd09b4eb568", "position": 52, "page_position": 4, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.011904761904761904, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 85, "quality_score": 55 } }, { "result_id": "f0dc5f1a65b63a3dc99d009006b44864", "position": 53, "page_position": 5, "retrieval_features": { "bm25_score": 0, "vector_score": 0.29424814616154626, "rrf_score": 0.011764705882352941, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 124, "quality_score": 45 } }, { "result_id": "fe67fffa8f0de0487f438e51c90baa42", "position": 54, "page_position": 6, "retrieval_features": { "bm25_score": -15.724642276763916, "vector_score": 0, "rrf_score": 0.011627906976744186, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 90, "quality_score": 55 } }, { "result_id": "b983ea3a1fb38d8c8284bdecc00d8a23", "position": 55, "page_position": 7, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2954189425207395, "rrf_score": 0.011363636363636364, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 63, "quality_score": 55 } }, { "result_id": "7612e2f28c08ff598fb9812047c51482", "position": 56, "page_position": 8, "retrieval_features": { "bm25_score": -15.10630178451538, "vector_score": 0, "rrf_score": 0.011363636363636364, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 124, "quality_score": 55 } }, { "result_id": "85f7f5d0e79fde4085f96025ec99c55c", "position": 57, "page_position": 9, "retrieval_features": { "bm25_score": -15.10630178451538, "vector_score": 0, "rrf_score": 0.011111111111111112, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 124, "quality_score": 55 } }, { "result_id": "24aa8ed83f53570e62d124da4cf36f50", "position": 58, "page_position": 10, "retrieval_features": { "bm25_score": -14.998390674591064, "vector_score": 0, "rrf_score": 0.01098901098901099, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 92, "quality_score": 55 } }, { "result_id": "781d0bb22af5a52255b78b7d2afa66d0", "position": 59, "page_position": 11, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2963937520980835, "rrf_score": 0.01098901098901099, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 124, "quality_score": 55 } }, { "result_id": "09b88e3020a9f41df9c4a1c348c51632", "position": 60, "page_position": 12, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0, "rrf_score": 0.010869565217391304, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 64, "quality_score": 55 } }, { "result_id": "1fbba28a67b6d6b9f5c37572fd732892", "position": 61, "page_position": 13, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0, "rrf_score": 0.010752688172043012, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 91, "quality_score": 55 } }, { "result_id": "608d83d690717e6e1f00629f6f147ddb", "position": 62, "page_position": 14, "retrieval_features": { "bm25_score": 0, "vector_score": 0.29692357778549194, "rrf_score": 0.010752688172043012, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 96, "quality_score": 55 } }, { "result_id": "e1a992cc483b9b13522173ca69b53f72", "position": 63, "page_position": 15, "retrieval_features": { "bm25_score": 0, "vector_score": 0.29706267732008107, "rrf_score": 0.010638297872340425, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 78, "quality_score": 55 } }, { "result_id": "2815fcfc85766b82f13cccb673284eb4", "position": 64, "page_position": 16, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0, "rrf_score": 0.010638297872340425, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 112, "quality_score": 55 } }, { "result_id": "2e0b768069ba4742703680f3b1bab161", "position": 65, "page_position": 17, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0, "rrf_score": 0.010526315789473684, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 105, "quality_score": 55 } }, { "result_id": "12b9611162f7c5c6fb073f3594ec2fdd", "position": 66, "page_position": 18, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2972518801689148, "rrf_score": 0.010526315789473684, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 106, "quality_score": 45 } }, { "result_id": "3971021563453976eb0aa6df2105be1c", "position": 67, "page_position": 19, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0, "rrf_score": 0.010416666666666666, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 84, "quality_score": 45 } }, { "result_id": "6448796982e8f48d09c86705f4f34d85", "position": 68, "page_position": 20, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2978626489639282, "rrf_score": 0.010309278350515464, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 85, "quality_score": 55 } }, { "result_id": "43964159ee60577e46c710082caa2193", "position": 69, "page_position": 21, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0, "rrf_score": 0.010101010101010102, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 93, "quality_score": 55 } }, { "result_id": "a8e5825c574c5841420c84c59b7beece", "position": 70, "page_position": 22, "retrieval_features": { "bm25_score": 0, "vector_score": 0.2980727553367615, "rrf_score": 0.01, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 84, "quality_score": 55 } }, { "result_id": "6666677ea3088b5f8c248db536c3bb91", "position": 71, "page_position": 23, "retrieval_features": { "bm25_score": -14.645976543426514, "vector_score": 0, "rrf_score": 0.01, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 124, "quality_score": 55 } }, { "result_id": "beec845ca71706afe71ef50bf5b2b05a", "position": 72, "page_position": 24, "retrieval_features": { "bm25_score": 0, "vector_score": 0.29808424126599653, "rrf_score": 0.009900990099009901, "text_match_title": false, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 124, "quality_score": 55 } } ] }, "context_signature": "PfN1rR3HDeeAYsXwC1ZSIuYPyWNDU2wVQyNglVcxe9o", "event_token": "PfN1rR3HDeeAYsXwC1ZSIuYPyWNDU2wVQyNglVcxe9o" } }